CAS NO: | 154039-60-8 |
包装 | 价格(元) |
10 mM * 1 mL in DMSO | 电议 |
1mg | 电议 |
5mg | 电议 |
10mg | 电议 |
50mg | 电议 |
100mg | 电议 |
200mg | 电议 |
生物活性 | Marimastat (BB2516) is a broad spectrum and orally bioavailable inhibitor ofMMPs, with potent activity againstMMP-9(IC50=3 nM),MMP-1(IC50=5 nM),MMP-2(IC50=6 nM),MMP-14(IC50=9 nM) andMMP-7(IC50=13 nM), used in the treatment ofcancer. Marimastat (BB2516) is an angiogenesis and metastasis inhibitor, which limits the growth and production of blood vessels. As an antimetatstatic agent it prevents malignant cells from breaching the basement membranes[1][2]. | ||||||||||||||||
IC50& Target |
| ||||||||||||||||
体外研究 (In Vitro) | Marimastat (BB2516) (1 μM) shows inhibition of vascular outgrowth, and selectively affects angiogenesis[3]. | ||||||||||||||||
体内研究 (In Vivo) | Animals receiving chemoradiation + Marimastat (BB2516) (8.7 mg/kg) have statistically significant delayed growth, compared to animals receiving chemoradiation alone. Marimastat (BB2516) may work in combination with chemotherapy and radiation to inhibit tumor growth[4]. | ||||||||||||||||
Clinical Trial | |||||||||||||||||
分子量 | 331.41 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C15H29N3O5 | ||||||||||||||||
CAS 号 | 154039-60-8 | ||||||||||||||||
中文名称 | 马立马司他 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 |
| ||||||||||||||||
溶解性数据 | In Vitro: DMSO : 100 mg/mL(301.74 mM;Need ultrasonic) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo: 请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百
|